[1] |
Chen M, Copley SJ, Viola P, et al. Radiomics and artificial intelligence for precision medicine in lung cancer treatment[J]. Semin Cancer Biol, 2023, 93: 97-113. doi:10.1016/j.semcancer.2023.05.004
|
[2] |
Wu Y, Li K, Liang S, et al. An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma[J]. Respir Res, 2023, 24(1): 142. doi:10.1186/s12931-023-02443-0
|
[3] |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022[J]. CA A Cancer J Clinicians, 2022, 72(1): 7-33. doi:10.3322/caac.21708
|
[4] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-49. doi:10.3322/caac.21660
|
[5] |
Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based trea-tment of lung adenocarcinoma[J]. Cell Death Dis, 2018, 9(2): 117. doi:10.1038/s41419-017-0063-y
|
[6] |
Wei X, Li X, Hu S, et al. Regulation of ferroptosis in lung adenocarcinoma[J]. Int J Mol Sci, 2023, 24(19): 14614. doi:10.3390/ijms241914614
|
[7] |
Zhang XF, Ma L, Xue M, et al. Advances in lymphatic metastasis of non-small cell lung cancer[J]. Cell Commun Signal, 2024, 22(1): 201. doi:10.1186/s12964-024-01574-1
|
[8] |
Zhai D, Zhou Y, Kuang X, et al. Lnc NR2F1-AS1 promotes breast cancer metastasis by targeting the miR-25-3p/ZEB2 axis[J]. Int J Med Sci, 2023, 20(9): 1152-62. doi:10.7150/ijms.86969
|
[9] |
Zhang C, Gong C, Li J, et al. Downregulation of long non-coding RNA LINC-PINT serves as a diagnostic and prognostic biomarker in patients with non-small cell lung cancer[J]. Oncol Lett, 2021, 21(3): 210. doi:10.3892/ol.2021.12471
|
[10] |
Liu R, Wang J, Zhang L, et al. GLIDR-mediated regulation of tumor malignancy and cisplatin resistance in non-small cell lung cancer via the miR-342-5p/PPARGC1A axis[J]. BMC Cancer, 2024, 24(1): 1126. doi:10.1186/s12885-024-12845-y
|
[11] |
Sun DE, Ye SY. Emerging roles of long noncoding RNA regulator of reprogramming in cancer treatment[J]. Cancer Manag Res, 2020, 12: 6103-12. doi:10.2147/cmar.s253042
|
[12] |
Guo L, Sun C, Xu S, et al. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer[J]. Thorac Cancer, 2019, 10(2): 128-36. doi:10.1111/1759-7714.12911
|
[13] |
Li D, Ma Y, Deng W, et al. Construction and analysis of lncRNA-associated CeRNA network in atherosclerotic plaque formation[J]. Biomed Res Int, 2022, 2022: 4895611. doi:10.1155/2022/4895611
|
[14] |
Lu S, Zeng L, Mo G, et al. Correction: Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p[J]. PLoS One, 2024, 19(12): e0317025. doi:10.1371/journal.pone.0317025
|
[15] |
Ma P, Kang S, Li H, et al. A novel lncRNA AC112721.1 promotes the progression of triple-negative breast cancer by directly binding to THBS1 and regulating miR-491-5p/C2CD2L axis[J]. Sci Rep, 2024, 14(1): 32056. doi:10.1038/s41598-024-83665-0
|
[16] |
Zhang H, Cai W, Miao Y, et al. Long non-coding RNA LINC01116 promotes the proliferation of lung adenocarcinoma by targeting miR-9-5p/CCNE1 axis[J]. J Cell Mol Med, 2024, 28(23): e70270. doi:10.1111/jcmm.70270
|
[17] |
Chen L, Chen X, Liu L, et al. miR-30b-3p inhibits the proliferation and invasion of lung adenocarcinoma by targeting COX6B1[J]. Zhongguo Fei Ai Za Zhi, 2022, 25(8): 567-74.
|
[18] |
Yu H, Zhang W, Xu XR, et al. Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironment[J]. Sci Rep, 2023, 13(1): 9682. doi:10.1038/s41598-023-35743-y
|
[19] |
Wang L, Xie X. STIL enhances the development of lung adeno-carcinoma by regulating the glycolysis pathway[J]. Oncol Res, 2025, 33(1): 123-32. doi:10.32604/or.2024.048562
|
[20] |
Jin X, Liu D, Kong D, et al. Dissecting the alternation landscape of mitochondrial metabolism-related genes in lung adenocarcinoma and their latent mechanisms[J]. Aging: Albany NY, 2023, 15(12): 5482-96. doi:10.18632/aging.204803
|
[21] |
Zhang Q, Chen X, Hu Y, et al. BIRC5 inhibition is associated with pyroptotic cell death via Caspase3-GSDME pathway in lung adenocarcinoma cells[J]. Int J Mol Sci, 2023, 24(19): 14663. doi:10.3390/ijms241914663
|
[22] |
Yu Y, Cai Y, Zhou H. LncRNA SNHG15 regulates autophagy and prevents cerebral ischaemia-reperfusion injury through mediating miR-153-3p/ATG5 axis[J]. J Cell Mol Med, 2024, 28(5): e17956. doi:10.1111/jcmm.17956
|
[23] |
Tan MY, Pan Q, Gong H, et al. Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway[J]. Pharmacol Res, 2023, 197: 106940. doi:10.1016/j.phrs.2023.106940
|
[24] |
Min H, Yang L, Xu X, et al. SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress[J]. Cell Cycle, 2023, 22(19): 2130-41. doi:10.1080/15384101.2023.2278339
|
[25] |
Beyrami M, Khodadadi I, Tavilani H, et al. Uncovering the relationship between YAP/WWTR1 (TAZ) genes expression and LncRNAs of SNHG15 HCP5 and LINC01433 in breast cancer tissues[J]. Pathol Res Pract, 2024, 257: 155286. doi:10.1016/j.prp.2024.155286
|
[26] |
Zhang W, Wang Y, Wan JZ, et al. COX6B1 relieves hypoxia/reoxygenation injury of neonatal rat cardiomyocytes by regulating mitochondrial function[J]. Biotechnol Lett, 2019, 41(1): 59-68. doi:10.1007/s10529-018-2614-4
|
[27] |
Jennions E, Olsson-Engman M, Visuttijai K, et al. A novel homozygous pathogenic missense variant in COX6B1: Further delineation of the phenotype[J]. Am J Med Genet A, 2024, 194(10): e63783. doi:10.1002/ajmg.a.63783
|
[28] |
Liu J, Chen T, Yang M, et al. Development of an oxidative phosphorylation-related and immune microenvironment prognostic signature in uterine corpus endometrial carcinoma[J]. Front Cell Dev Biol, 2021, 9: 753004. doi:10.3389/fcell.2021.753004
|
[29] |
Stein J, Tenbrock J, Kristiansen G, et al. Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma[J]. Int J Urol, 2019, 26(9): 910-6. doi:10.1111/iju.14040
|
[30] |
Zhan Z, Lin K, Wang T. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma[J]. BMC Ophthalmol, 2024, 24(1): 204. doi:10.1186/s12886-024-03441-6
|